Cargando…
WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells
BACKGROUND: Development of metastases and drug resistance are still a challenge for a successful systemic treatment in breast cancer (BC) patients. One of the mechanisms that confer metastatic properties to the cell relies in the epithelial-to-mesenchymal transition (EMT). Moreover, both EMT and met...
Autores principales: | Punzi, Simona, Balestrieri, Chiara, D’Alesio, Carolina, Bossi, Daniela, Dellino, Gaetano Ivan, Gatti, Elena, Pruneri, Giancarlo, Criscitiello, Carmen, Lovati, Giulia, Meliksetyan, Marine, Carugo, Alessandro, Curigliano, Giuseppe, Natoli, Gioacchino, Pelicci, Pier Giuseppe, Lanfrancone, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873410/ https://www.ncbi.nlm.nih.gov/pubmed/31752957 http://dx.doi.org/10.1186/s13058-019-1216-y |
Ejemplares similares
-
RNAi screens identify CHD4 as an essential gene in breast cancer growth
por: D'Alesio, Carolina, et al.
Publicado: (2016) -
Development of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXs
por: Punzi, Simona, et al.
Publicado: (2019) -
Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process
por: Melixetian, Marine, et al.
Publicado: (2022) -
Long non‐coding RNA TINCR suppresses metastatic melanoma dissemination by preventing ATF4 translation
por: Melixetian, Marine, et al.
Publicado: (2021) -
Halting 'research waste'
por: Shamsoddin, E., et al.
Publicado: (2021)